CYTOR and osteosarcoma: High expression of LINC00152 has been observed in multiple types of tumors, including breast cancer, ovarian cancer, hepatocellular cancer, lung cancer, leukemia, bladder cancer, nasopharyngeal cancer, gallbladder cancer, osteosarcoma, laryngeal cancer, thyroid cancer, retinoblastoma, head and neck squamous cell cancer, and pancreatic cancer (Figure 2).